Biblio

2024
Ke F, Benet ZL, Shelyakin P, Britanova OV, Gupta N, Dent AL, Moore BB, Grigorova IL. Targeted checkpoint control of B cells undergoing positive selection in germinal centers by follicular regulatory T cells. Proc Natl Acad Sci U S A. 2024;121(5):e2304020121.
Karbassi E, Padgett R, Bertero A, Reinecke H, Klaiman JM, Yang X, Hauschka SD, Murry CE. Targeted CRISPR activation is functional in engineered human pluripotent stem cells but undergoes silencing after differentiation into cardiomyocytes and endothelium. Cell Mol Life Sci. 2024;81(1):95.
Jiang Y, Yu M, Song Z-F, Wei Z-Y, Huang J, Qian H-Y. Targeted Delivery of Mesenchymal Stem Cell-Derived Bioinspired Exosome-Mimetic Nanovesicles with Platelet Membrane Fusion for Atherosclerotic Treatment. Int J Nanomedicine. 2024;19:2553-2571.
Zhang Z, Zhang S, Wong HTing, Li D, Feng B. Targeted Gene Insertion: The Cutting Edge of CRISPR Drug Development with Hemophilia as a Highlight. BioDrugs. 2024.
Glaser KM, Egg M, Hobitz S, Mitterer M, Schain-Zota D, Schönberger K, Schuldes K, Cabezas-Wallscheid N, Lämmermann T, Rambold A, et al. Targeted Metabolomics on Rare Primary Cells. J Vis Exp. 2024;(204).
de Vries ISNaarmann, Dieterich C. Targeted Sequencing of Circular RNAs for Illumina-Based Counting and Nanopore Structure Determination. Methods Mol Biol. 2024;2765:127-142.
Eichholz T, Heubach F, Arendt A-M, Seitz C, Brecht IB, Ebinger M, Flaadt T, Süsskind D, Richter L, Hülsenbeck I, et al. Targeted therapies in retinoblastoma: GD2-directed immunotherapy following autologous stem cell transplantation and evaluation of alternative target B7-H3. Cancer Immunol Immunother. 2024;73(1):19.
Yang Q, Gao W, Li X, Li X, Zhou X, Li W, Zhou C, Luo A, Liu Z. Targeting ABCA1 via Extracellular vesicle-Encapsulated Staurosporine as a Therapeutic Strategy to enhance Radiosensitivity. Adv Healthc Mater. 2024:e2400381.
Chen X, Sun X, Ge Y, Zhou X, Chen J-F. Targeting adenosine A receptors for early intervention of retinopathy of prematurity. Purinergic Signal. 2024.
Du J, Wang Y, Wu C, Zhang X, Zhang X, Xu X. Targeting bone homeostasis regulation: potential of traditional Chinese medicine flavonoids in the treatment of osteoporosis. Front Pharmacol. 2024;15:1361864.
Wadhwa K, Chauhan P, Kumar S, Pahwa R, Verma R, Goyal R, Singh G, Sharma A, Rao N, Kaushik D. Targeting brain tumors with innovative nanocarriers: bridging the gap through the blood-brain barrier. Oncol Res. 2024;32(5):877-897.
Alcala S, Villarino L, Ruiz-Cañas L, Couceiro JR, Martínez-Calvo M, Palencia-Campos A, Navarro D, Cabezas-Sainz P, Rodriguez-Arabaolaza I, Cordero-Barreal A, et al. Targeting cancer stem cell OXPHOS with tailored ruthenium complexes as a new anti-cancer strategy. J Exp Clin Cancer Res. 2024;43(1):33.
Zhang X, Lao M, Yang H, Sun K, Dong Y, He L, Jiang X, Wu H, Jiang Y, Li M, et al. Targeting cancer-associated fibroblast autophagy renders pancreatic cancer eradicable with immunochemotherapy by inhibiting adaptive immune resistance. Autophagy. 2024.
Mukhtar AB, Morgan HJ, Gibbs A, Davies GE, Lovatt C, Patel GK. Targeting CD20-expressing malignant melanoma cells augments BRAF inhibitor killing. Br J Dermatol. 2024.
Mediratta K, El-Sahli S, Marotel M, Awan MZ, Kirkby M, Salkini A, Kurdieh R, Abdisalam S, Shrestha A, Di Censo C, et al. Targeting CD73 with flavonoids inhibits cancer stem cells and increases lymphocyte infiltration in a triple-negative breast cancer mouse model. Front Immunol. 2024;15:1366197.
Tripathi T, Yadav J, Janjua D, Chaudhary A, Joshi U, Senrung A, Chhokar A, Aggarwal N, Bharti AChandra. Targeting Cervical Cancer Stem Cells by Phytochemicals. Curr Med Chem. 2024.
Cancilla D, Rettig MP, Karpova D, Thakellapalli H, Singh M, Meyers MJ, Ruminski PG, Christ S, Chendamarai E, Gao F, et al. Targeting CXCR4, VLA-4 and CXCR2 for Hematopoietic Stem Cell Mobilization. Blood Adv. 2024.
Zhu C, Ke S, Li Y, Zhang W, Che Y, Zhang R, Huang P, Xu T. Targeting DEP domain containing 1 in anaplastic thyroid carcinoma: Implications for stemness regulation and malignant phenotype suppression. Heliyon. 2024;10(5):e27150.
Liu C-C, Chen L, Cai Y-W, Chen Y-F, Liu Y-M, Zhou Y-J, Shao Z-M, Da Yu K-. Targeting EMSY-mediated methionine metabolism is a potential therapeutic strategy for triple-negative breast cancer. Cell Rep Med. 2024:101396.
Ashoub MHossein, Razavi R, Heydaryan K, Salavati-Niasari M, Amiri M. Targeting ferroptosis for leukemia therapy: exploring novel strategies from its mechanisms and role in leukemia based on nanotechnology. Eur J Med Res. 2024;29(1):224.
Leung WK, Chavez AGTorres, French-Kim M, Shafer P, Mamonkin M, Hill LQC, Kuvalekar M, Velazquez Y, Watanabe A, Watanabe N, et al. Targeting IDH2R140Q and other neoantigens in acute myeloid leukemia. Blood. 2024.
Kakafika MG, Lyta AA, Gavriilidis GI, Tsiftsoglou SA, Miliotou AN, Pappas IS, Vizirianakis IS, Papadopoulou LC, Tsiftsoglou AS. Targeting mitochondrial bioenergetics by combination treatment with imatinib and dichloroacetate in human erythroleukemic K‑562 and colorectal HCT‑116 cancer cells. Int J Oncol. 2024;64(4).
Venkatraman S, Balasubramanian B, Thuwajit C, Meller J, Tohtong R, Chutipongtanate S. Targeting MYC at the intersection between cancer metabolism and oncoimmunology. Front Immunol. 2024;15:1324045.
Ahmad SSayeed, Lim JHo, Ahmad K, Chun HJin, Hur SJin, Lee EJu, Choi I. Targeting myostatin using quercetin as a media supplement to improve myogenesis for cultured meat production: An and study. Curr Res Food Sci. 2024;8:100678.
Hong S-H, Castro G, Wang D, Nofsinger R, Kane M, Folias A, Atkins AR, Yu RT, Napoli JL, Sassone-Corsi P, et al. Targeting nuclear receptor corepressors for reversible male contraception. Proc Natl Acad Sci U S A. 2024;121(9):e2320129121.

Pages